Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2010
06/16/2010CN101095879B Chinese traditional medicine for treating tuberculosis disease and the preparation method thereof
06/16/2010CN101085241B Internal-applied traditional Chinese medicinal composition for treating viral myocarditis
06/16/2010CN101052373B Suction tablet containing octenidine for oral and pharyngeal cavity inflammation
06/16/2010CN101048403B Heterocyclic antiviral compounds
06/16/2010CN101041066B The application of r-sHSA for treating chronic liver disease
06/16/2010CN101039669B Novel antimicrobial medicine
06/16/2010CN101031313B Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality
06/15/2010US7737282 amorphous compound of lansoprazole; antiulcer agent
06/15/2010US7737256 anti-HIV action of uPAR-activators or activated uPAR molecules; diagnosis of cancer, AIDS and inflammatory diseases; treatment of septic shock, rheumatoid arthritis, Crohn's disease, and chronic arthritis
06/15/2010US7737177 Combining solution of pseudomonic acid in water-immiscible solvent with suspension or solution of calcium C2-C12 organic carboxylate in aqueous solvent to form aqueous and nonaqueous phases, wherein mupirocin calcium dihydrate precipitates
06/15/2010US7737162 Viral inhibitors
06/15/2010US7737144 1-Ethyl-6-methyl-3-phenyl-1H-pyrinido[5,4-e]1,2,4]triazine-5,7-dione, used for lowering blood sugar, treating non-insulin dependent diabetes and insulin resistance; antidiabetic agents
06/15/2010US7737129 Treating sepsis, septicemia and septic shock
06/15/2010US7737124 transfecting a packaging cell line with a retroviral construct, then recovering a recombinant retrovirus from the packaging cell line and infecting a target cell ex vivo with the recombinant retrovirus; downregulating chemokine receptors (CCR5); treatment of viral diseases
06/15/2010US7736899 Cells and method for producing proteins comprising an unconventional amino acid
06/15/2010US7736873 An isolated nucleic acid molecule comprising a nucleotide sequence which encodes the polypeptide comprising the outer membrane protein antigens of gramnegative bacteria, which can be used to prevent and treat gramnegative bacteria infection in mammals, such as humans; immunology; vaccines
06/15/2010US7736847 Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics
06/15/2010US7736658 Canine combination vaccines
06/15/2010US7736652 Comprises immunoglobulin-immunostimulant fusion protein for use in preventing and treating infections, cancer and autoimmune disorders; genetic vaccination; gene therapy
06/15/2010US7736649 preventing the viral entry process into target cells, by inhibiting the binding of viral surface glycoprotein to cell surface CD4, to fusion coreceptors CCR5 chemokine receptors and the transient conformation fusion intermediate that ultimately folds into a conformation capable of mediating fusion
06/15/2010US7736622 Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
06/15/2010CA2493391C Novel thiophene glycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
06/15/2010CA2405050C Production of tcr gamma delta t cells
06/15/2010CA2402219C Novel echinocandin derivatives, preparation method and use thereof as fungicides
06/15/2010CA2393650C Novel 1,8-naphthyridin-2(1h)-one derivatives
06/15/2010CA2351714C Semi-hydrochloride of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
06/15/2010CA2295940C Epitopes of shigella like toxin and their use as vaccine and in diagnosis
06/12/2010CA2646383A1 Inhibitors of lethal factor protease of anthrax toxin
06/10/2010WO2010065959A1 Method of preparing adenosine-resistant anti-tumor t lymphocytes for adoptive immunotherapy
06/10/2010WO2010065905A2 Compounds having antiparasitic or anti-infectious activity
06/10/2010WO2010065747A2 Intramammary teat sealant
06/10/2010WO2010065577A1 Hepatitis c virus inhibitors
06/10/2010WO2010065159A1 Inhibition of dna polymerases to augment chemotherapeutic and antimicrobial agents
06/10/2010WO2010065110A2 Antimicrobials
06/10/2010WO2010064951A1 New quinoline derivatives, a method for the production and the use thereof for treating microbacterial infections and a pharmaceutical composition based on said derivatives
06/10/2010WO2010064790A1 Ecklonia cava-derived phloroglucinol derivatives having inhibitory activities against hiv-1
06/10/2010WO2010064597A1 Piperidine derivative
06/10/2010WO2010064425A1 Method for inhibiting proliferation of cells
06/10/2010WO2010064243A1 GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
06/10/2010WO2010063996A2 Antibacterial compounds
06/10/2010WO2010036408A3 Lysk endolysin is synergistic with lysostaphin against mrsa
06/10/2010WO2010033986A3 Dna cytosine deaminase inhibitors
06/10/2010WO2010027736A3 Antimicrobial protein compositions and production therefor from marine bacteria
06/10/2010WO2010022238A3 Anti-flavivirus therapeutic
06/10/2010WO2010021681A3 Compositions and methods for treatment of viral diseases
06/10/2010WO2009149443A3 A metal-citrate transporter antigen from streptomyces coelicolor and uses thereof
06/10/2010WO2009095588A3 Synthesis of novel neamine derivatives and use thereof as antibacterial agents
06/10/2010US20100146659 Plant Virus Designated Tomato Marchitez Virus
06/10/2010US20100145026 Antibody for ADCC And Inducing Cytokine Production
06/10/2010US20100144847 Fusion polypeptide suitable as a cytotoxin
06/10/2010US20100144846 Oligoribonucleotides and uses thereof
06/10/2010US20100144841 Control of nk cell function and survival by modulation of ship activity
06/10/2010US20100144833 RNA interference; respiratory syncytial virus (RSV), parainfluenza virus (PIV); down-regulation of a gene(s) of a respiratory virus by oligonucleotides via RNA interference which are administered locally to the lungs and nasal passage via inhalation/intranasally or systemically via injection/intravenous
06/10/2010US20100144828 Caffeoylquinic acid derivatives containing nitrogen, and preparation method, pharmaceutical composition and usage thereof
06/10/2010US20100144825 Renin Inhibitors
06/10/2010US20100144804 Polymorph of a Pharmaceutical
06/10/2010US20100144780 salts of N-acridonacetic acid such as N-(1-deoxy-D-glucitol-1-yl)-N-ethyl ammonium 9-oxoacridine-10-ylacetate, having immunomodulating, antiparasitic, antisclerotic, antiviral, antibacterial, antifungal, antiphlogistic, antitumor, radioprotective and stressprotective activities
06/10/2010US20100144768 Kinase inhibitor compounds
06/10/2010US20100144758 Azaindole p2x3 and p2x2/3 modulators
06/10/2010US20100144752 Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes
06/10/2010US20100144735 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
06/10/2010US20100144726 Novel indolic derivatives, their preparation processes and their uses in particular as antibacterials
06/10/2010US20100144719 Pharmaceutical suspension
06/10/2010US20100144717 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
06/10/2010US20100144712 Triazole derivatives having antifungal activity, method for the preparation thereof, and pharmaceutical composition comprising the same
06/10/2010US20100144699 Combination Medicaments for Treating Bacterial Infections
06/10/2010US20100144688 23-Substituted Derivatives of Lupane-type Pentacyclic Triterpenoids
06/10/2010US20100144676 Oleyl phosphocholine
06/10/2010US20100144664 Carbocyclic compounds and methods for treating emerging disease, including influenza and venezuela equine encephalitis virus
06/10/2010US20100144662 Aminoglycoside antibiotics targeting bacterial 16s ribosomal rna
06/10/2010US20100144658 Novel antibiotics, bispolides a1, a2, and a3 as well as bispolides b1, b2a, b2b and b3 and processes for producing said antibiotics
06/10/2010US20100144655 Organic compounds
06/10/2010US20100144649 Compounds for enzyme inhibition
06/10/2010US20100144648 Compounds for enzyme inhibition
06/10/2010US20100144647 Dual Acting Prodrugs
06/10/2010US20100144643 Polymeric Biosufactants
06/10/2010US20100144630 Compositions, methods and uses for inhibition and/or treatment of influenza infection
06/10/2010US20100144626 Treatment of Multi-Drug Resistant Bacterial Infections
06/10/2010US20100144619 Antimicrobial Protein Specific to Staphylococcus Aureus
06/10/2010US20100144618 Compositions containing an intestinal trefoil peptide and a mucoadhesive
06/10/2010US20100144613 Combined use of DPP-IV Inhibitors and Gastrin Compounds
06/10/2010US20100144608 Macrocyclic hepatitis C serine protease inhibitors
06/10/2010US20100144598 Natural Polypeptides For Oral Health Care
06/10/2010US20100143514 Antiviral agents containing a fermentation product of garlic by lactic acid bacteria
06/10/2010US20100143510 Intramammary teat sealant
06/10/2010US20100143490 Composite material
06/10/2010US20100143454 Flavivirus NS5A Proteins For the Treatment of HIV
06/10/2010US20100143440 Ul97 inhibitors for treatment of proliferative disorders
06/10/2010US20100143418 Immunising Against Meningococcal Serogroup Y Using Proteins
06/10/2010US20100143417 Compositions and methods for controlling diseases in animals
06/10/2010US20100143416 Alpha-defensins as anthrax immunotherapeutis
06/10/2010US20100143415 Streptococcus Pneumoniae Antigens
06/10/2010US20100143414 Pneumococcal serotypes
06/10/2010US20100143412 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
06/10/2010US20100143411 Method for identification of t-lymphocyte antigens
06/10/2010US20100143410 Polypeptide fragments of the hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
06/10/2010US20100143408 Papillomavirus vaccines
06/10/2010US20100143403 Methods and compositions for vaccination of poultry
06/10/2010US20100143399 Process for manufacturing vaccines
06/10/2010US20100143395 Material with immunogenicity
1 ... 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 ... 1798